GUBRF vs MEDTR Comparison
Price, market cap, valuation, profitability and leverage metrics of GUBRF and MEDTR side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | GUBRF | MEDTR | Sector median |
|---|---|---|---|
| Last price (TL) | 435.25 | 18.22 | 18.72 |
| Daily change | −4.97% | −6.08% | −6.10% |
| Market cap | TRY 145.4B | TRY 2.2B | TRY 4.3B |
| P/E | 19.22 | 66.43 | 17.35 |
| P/B | 3.89 | 0.69 | 1.09 |
| Dividend yield | — | 0.44% | 0.90% |
| Return on equity | 23.87% | 1.14% | 1.78% |
| Free float | 20.28% | 20.21% | 37.21% |
Popular Comparisons
Related Pages
About the GUBRF vs MEDTR Comparison
Price, market cap, valuation multiples, profitability and leverage of GUBRF (Gübre Fabrik.) and MEDTR (Meditera Tibbi Malzeme) side by side as of Sep 28, 2026, 13:57. Of the 14 metrics compared, GUBRF leads in 7 and MEDTR leads in 7.
Highlights: Daily change: GUBRF leads (−4.97% vs −6.08%). Market cap: GUBRF leads (TRY 145.4B vs TRY 2.2B). P/E: GUBRF leads (19.22 vs 66.43). P/B: MEDTR leads (0.69 vs 3.89). EV/EBITDA: MEDTR leads (7.60 vs 11.70). EV/Sales: MEDTR leads (1.36 vs 3.90). Gross margin: MEDTR leads (33.71% vs 26.69%). EBITDA margin (annual): GUBRF leads (22.84% vs 3.58%).
Frequently Asked Questions
Is GUBRF or MEDTR cheaper?
By P/E, GUBRF is cheaper (19.22 vs 66.43); by P/B, MEDTR trades at the lower multiple (3.89 vs 0.69).
Which is more profitable, GUBRF or MEDTR?
Annual net margin is 13.44% for GUBRF and 1.35% for MEDTR; return on equity is 23.87% for GUBRF and 1.14% for MEDTR.
Which is more leveraged, GUBRF or MEDTR?
The leverage ratio is 41.50 for GUBRF and 15.79 for MEDTR; net debt/EBITDA is −0.39 for GUBRF and — for MEDTR. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.